{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:59Z","timestamp":1787026499151,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014857","name":"National Natural Science Foundation of China-Guangdong Joint Fund","doi-asserted-by":"publisher","award":["81771295 , 81230027"],"award-info":[{"award-number":["81771295 , 81230027"]}],"id":[{"id":"10.13039\/501100014857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cell-based assays (CBAs) and radioimmunoprecipitation assay (RIPA) are the most sensitive methods for identifying anti-acetylcholine receptor (AChR) antibody in myasthenia gravis (MG). But CBAs are limited in clinical practice by transient transfection. We established a stable cell line (KL525) expressing clustered AChR by infecting HEK 293T cells with dual lentiviral vectors expressing the genes encoding the human AChR \u03b11, \u03b21, \u03b4, \u03f5 and the clustering protein rapsyn. We verified the stable expression of human clustered AChR by immunofluorescence, immunoblotting, and real-time PCR. Fluorescence-activated cell sorting (FACS) was used to detect anti-AChR antibodies in 103 MG patients and 58 healthy individuals. The positive results of MG patients reported by the KL525 was 80.6% (83\/103), 29.1% higher than the 51.4% (53\/103) of RIPA. 58 healthy individuals tested by both the KL525 CBA and RIPA were all negative. In summary, the stable expression of clustered AChR in our cell line makes it highly sensitive and advantageous for broad clinical application in CBAs.<\/jats:p>","DOI":"10.3389\/fimmu.2021.666046","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T04:52:31Z","timestamp":1625719951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["A Stable Cell Line Expressing Clustered AChR: A Novel Cell-Based Assay for Anti-AChR Antibody Detection in Myasthenia Gravis"],"prefix":"10.3389","volume":"12","author":[{"given":"Yu","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghua","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiajun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangtai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia Gravis - Autoantibody Characteristics and Their Implications for Therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/85520","article-title":"Auto-Antibodies to the Receptor Tyrosine Kinase Musk in Patients With Myasthenia Gravis Without Acetylcholine Receptor Antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-51220-4_11","article-title":"Myasthenia Gravis: Clinical Features, Immunology, and Therapies","volume-title":"Inflammatory Disorders of the Nervous System","author":"Richeh","year":"2017"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A Comprehensive Analysis of the Epidemiology and Clinical Characteristics of Anti-Lrp4 in Myasthenia Gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.2032","article-title":"Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin","volume":"73","author":"Cortes-Vicente","year":"2016","journal-title":"JAMA Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-09-03000.2001","article-title":"Rearrangement of Nicotinic Receptor Alpha Subunits During Formation of the Ligand Binding Sites","volume":"21","author":"Mitra","year":"2001","journal-title":"J Neurosci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.2277","article-title":"Seronegative Myasthenia Gravis-A Vanishing Disorder","volume":"73","author":"Kaminski","year":"2016","journal-title":"JAMA Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn092","article-title":"Igg1 Antibodies to Acetylcholine Receptors in \u2018Seronegative\u2019 Myasthenia Gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.0203","article-title":"Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis","volume":"72","author":"Rodriguez Cruz","year":"2015","journal-title":"JAMA Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"10193","DOI":"10.1038\/srep10193","article-title":"Clinical Application of Clustered-Achr for the Detection of Snmg","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13300","article-title":"Multiple Antibody Detection in \u2018Seronegative\u2019 Myasthenia Gravis Patients","volume":"24","author":"Hong","year":"2017","journal-title":"Eur J Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25154","article-title":"Characteristics of Acetylcholine-Receptor-Antibody-Negative Myasthenia Gravis in a South African Cohort","volume":"54","author":"Huda","year":"2016","journal-title":"Muscle Nerve"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0185976","DOI":"10.1371\/journal.pone.0185976","article-title":"Analysis of Peripheral B Cells and Autoantibodies Against the Anti-Nicotinic Acetylcholine Receptor Derived From Patients With Myasthenia Gravis Using Single-Cell Manipulation Tools","volume":"12","author":"Makino","year":"2017","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0193723","DOI":"10.1371\/journal.pone.0193723","article-title":"Myasthenia Gravis Seronegative for Acetylcholine Receptor Antibodies in South Korea: Autoantibody Profiles and Clinical Features","volume":"13","author":"Park","year":"2018","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801295","article-title":"Autoantibodies Against Neurologic Antigens in Nonneurologic Autoimmunity","volume":"202","author":"Stathopoulos","year":"2019","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2019.01.016","article-title":"Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis","volume":"98","author":"Yan","year":"2019","journal-title":"Pediatr Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1552","article-title":"A Transfected Human Muscle Cell Line Expressing the Adult Subtype of the Human Muscle Acetylcholine Receptor for Diagnostic Assays in Myasthenia Gravis","volume":"47","author":"Beeson","year":"1996","journal-title":"Neurology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20454","article-title":"A Rapid, Fluorescence-Based Assay for Detecting Antigenic Modulation of the Acetylcholine Receptor on Human Cell Lines","volume":"76","author":"Keefe","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"key":"B19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0304-3940(96)12488-5","article-title":"Stable Functional Expression of the Adult Subtype of Human Muscle Acetylcholine Receptor Following Transfection of the Human Rhabdomyosarcoma Cell Line te671 With cDNA Encoding the Epsilon Subunit","volume":"207","author":"Beeson","year":"1996","journal-title":"Neurosci Lett"},{"key":"B20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1309\/AJCPYEOR6SGE8ZLU","article-title":"Detection of Acetylcholine Receptor Modulating Antibodies by Flow Cytometry","volume":"143","author":"Lozier","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia Gravis: Recommendations for Clinical Research Standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23882","article-title":"Do Acetylcholine Receptor and Striated Muscle Antibodies Predict the Presence of Thymoma in Patients With Myasthenia Gravis","volume":"49","author":"Choi Decroos","year":"2014","journal-title":"Muscle Nerve"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0735","article-title":"Autoantibody Profiles and Neurological Correlations of Thymoma","volume":"10","author":"Vernino","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20854","article-title":"Frequency of Seronegativity in Adult-Acquired Generalized Myasthenia Gravis","volume":"36","author":"Chan","year":"2007","journal-title":"Muscle Nerve"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.052415","article-title":"The Features of Myasthenia Gravis With Autoantibodies to Musk","volume":"76","author":"Lavrnic","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.043125","article-title":"Patterns and Severity of Neuromuscular Transmission Failure in Seronegative Myasthenia Gravis","volume":"76","author":"Nemoto","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-829589","article-title":"Seronegative Myasthenia Gravis","volume":"24","author":"Vincent","year":"2004","journal-title":"Semin Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mus.20069","article-title":"Clinical Comparison of Muscle-Specific Tyrosine Kinase (Musk) Antibody-Positive and -Negative Myasthenic Patients","volume":"30","author":"Zhou","year":"2004","journal-title":"Muscle Nerve"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20061","article-title":"Detection and Characterization of Musk Antibodies in Seronegative Myasthenia Gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical Aspects of Musk Antibody Positive Seronegative Mg","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-Lrp4 Autoantibodies in Achr- and Musk-Antibody-Negative Myasthenia Gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2003.00678.x","article-title":"Disease Severity and Outcome in Thymoma Myasthenia Gravis: A Long-Term Observation Study","volume":"10","author":"Romi","year":"2003","journal-title":"Eur J Neurol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.6.885","article-title":"Anti-Titin Antibodies in Myasthenia Gravis: Tight Association With Thymoma and Heterogeneity of Nonthymoma Patients","volume":"58","author":"Yamamoto","year":"2001","journal-title":"Arch Neurol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12270","article-title":"Antibodies to Clustered Acetylcholine Receptor: Expanding the Phenotype","volume":"21","author":"Devic","year":"2014","journal-title":"Eur J Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archneurol.2012.437","article-title":"Presence and Pathogenic Relevance of Antibodies to Clustered Acetylcholine Receptor in Ocular and Generalized Myasthenia Gravis","volume":"69","author":"Jacob","year":"2012","journal-title":"Arch Neurol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.0205","article-title":"Unraveling the Enigma of Seronegative Myasthenia Gravis","volume":"72","author":"Vernino","year":"2015","journal-title":"JAMA Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.666046\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T04:52:34Z","timestamp":1625719954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.666046\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2021.666046"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.666046","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,8]]},"article-number":"666046"}}